RESPONSE GENETICS INC - 76123U105
Sector:
Healthcare
· Industry:
In Vitro & In Vivo Diagnostic Substances
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2014
· Q1 2014
Value (USD)
Total reported value ($000)
$20.05M
QoQ value delta ($000)
-$1.373M
(-6.41%)
Implied price effect (QoQ)
-3.88%
Shares
Total shares
17,534,289
QoQ shares delta
-472,799
(-2.63%)
Total shares held by funds (by quarter)
Top holders (Q2 2014)
Top 25 only
Full list
Partial Q2 2014 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 7,140 | 6,000,000 | 0.48% |
| LANSDOWNE PARTNERS LIMITED PARTNERSHIP | 4,528 | 3,805,161 | 0.04% |
| 12 West Capital Management LP | 2,913 | 2,447,617 | 0.47% |
| Becker Drapkin Management, L.P. | 2,407 | 2,022,890 | 1.51% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 2,134 | 2,319,879 | 0.27% |
| VANGUARD GROUP INC | 599 | 651,091 | 0.0% |
| FIRST MANHATTAN CO | 107 | 90,496 | 0.0% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 60 | 49,400 | 0.0% |
| GOLDMAN SACHS GROUP INC | 42 | 35,124 | 0.0% |
| NORTHERN TRUST CORP | 41 | 34,527 | 0.0% |
| KCG Holdings, Inc. | 25 | 21,548 | 0.0% |
| DOMINI SOCIAL INVESTMENTS LLC | 24 | 26,495 | 1.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 17 | 15,003 | 0.0% |
| GUGGENHEIM CAPITAL LLC | 15 | 12,778 | 0.0% |
| CITIGROUP INC | 1 | 1,050 | 0.0% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1 | 553 | 0.0% |
| MORGAN STANLEY | 0 | 65 | 0.0% |
| BNP PARIBAS ARBITRAGE, SA | 0 | 612 | 0.0% |